Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: A multi-centre cohort study
Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: A multi-centre cohort study
Body mass index (BMI) and cardiometabolic comorbidities such as cardiovascular disease and type 2 diabetes have been studied as negative prognostic factors in cancer survival, but possible dependencies in the mechanisms underlying these associations remain largely unexplored.